Ancefa

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ancefa

What is Ancefa? (Cefadroxil)

Property Description
Active ingredient Cefadroxil (Monohydrate)
Form Capsule, Tablet, Oral Suspension
Pharmacological class First-Generation Cephalosporin Antibiotic
Common use Treating susceptible bacterial infections
Origin Semisynthetic

What Type of Antibiotic is Ancefa (Cefadroxil)?

Ancefa is a prescription-only medicine containing the active component Cefadroxil. This drug is definitively classified within the pharmacological class of first-generation cephalosporins, a specific type of semisynthetic beta-lactam antibiotic used for systemic administration. The clinical utility of Cefadroxil is well-supported by pharmacological studies, which recognize its distinct effectiveness profile against susceptible bacterial organisms, such as those causing skin or urinary tract infections. It is a single-ingredient product, confirming that its action is derived solely from the Cefadroxil compound.


Composition, Origin, and Available Forms

The therapeutic action is derived entirely from the active ingredient Cefadroxil, which is typically manufactured and supplied as the monohydrate salt. The semisynthetic origin means the compound is a chemically modified derivative, developed to enhance stability and absorption compared to purely natural antibiotics. For patient use, the drug is available for oral administration in multiple drug forms suitable for different needs, including capsules, tablets, and a powder for oral suspension for liquid consumption. Cefadroxil is often clinically recognized for its ability to achieve efficacy with a less frequent dosing schedule, which is a practical factor in supporting patient adherence to therapy.


How Does Cefadroxil Generally Help Treat Infections?

The general purpose of Cefadroxil is to act as a bactericidal agent, meaning it exerts its effect by directly killing the susceptible bacteria that cause an infection. Its mode of action involves interfering with the vital process of bacterial cell wall synthesis. By disrupting the formation and structural integrity of this outer layer—a necessary component for bacterial survival—the medication eliminates the underlying pathogen, leading to the resolution of the bacterial illness.

What side effects are possible with Ancefa?

Possible Side Effects and Safety Information

The safety profile of Ancefa (Cefadroxil) is based on data formally documented by government regulatory agencies, detailing adverse reactions by affected system and frequency.

Frequency-Classified Adverse Reactions

Adverse reactions are organized according to frequency bands established in official regulatory documents:

  • Common (1% to 10%): Includes gastrointestinal effects (diarrhea, nausea, vomiting, dyspepsia, abdominal pain) and skin/dermatological reactions (rash, pruritus, urticaria).
  • Uncommon (0.1% to 1%): Primarily involves superinfections, such as vaginal mycoses (thrush) due to the overgrowth of non-susceptible organisms.
  • Rare/Very Rare (< 0.1%): Involves events like Angioedema, Agranulocytosis (a blood disorder), and significant increases in liver enzymes.

Serious Adverse Reactions and Safety Constraints

Regulatory sources explicitly document certain severe, though infrequent, risks:

Category Documented Serious Reaction/Constraint
Severe Allergic Reactions Anaphylactic Shock, Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).
Gastrointestinal Risk Clostridium difficile-associated diarrhea (CDAD), which can range to fatal colitis.
Blood/Organ Risk Hemolytic Anemia and nephrotoxicity (kidney damage).

Population and Duration Notes

The medicine is contraindicated in individuals with a known allergy to Cefadroxil or the cephalosporin class of antibiotics. Caution is required for patients with impaired renal function due to the risk of accumulation. Patients with a history of penicillin allergy should be prescribed Cefadroxil with caution due to the documented potential for cross-sensitivity. Prolonged use may result in the risk of superinfection.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Ancefa (cefazolin) is uncommon, particularly because it is typically administered in a healthcare setting. However, it is essential to be aware of the potential signs and the appropriate immediate action.

Documented Overdose Symptoms

Symptoms reported in cases of overdose, or with exposure to high doses, generally affect the central nervous system and the injection site. These include:

  • Neurological effects: Seizures (fits), headache, dizziness, and paresthesia (tingling sensation in the fingers or toes).
  • Vascular reactions: Pain and inflammation of the veins (phlebitis) near the site of injection.

Critical Risk Factor

Severe neurological toxicity, including life-threatening seizures, has been specifically reported when cefazolin is administered by the intrathecal route (injection into the fluid surrounding the spinal cord). This is considered an unapproved and high-risk method of use.

When to Seek Immediate Medical Attention

If an overdose is suspected, or if any severe symptoms are observed, immediate emergency action is required.

  • Immediately call emergency services (such as 911 or the local emergency number) or a poison control center for advice.
  • Urgent medical attention is mandatory if the person has collapsed, is having a seizure, is experiencing trouble breathing, or cannot be awakened.

Therapeutic Uses of Ancefa

What Ancefa Treats: Main Uses and Benefits

Ancefa is commonly used in conditions presenting with systemic or localized discomfort, encompassing key therapeutic areas like the skin and soft tissues, the uncomplicated urinary tract, and the throat. The medication is primarily applied in clinical settings that involve acute or unstable symptom patterns, such as uncomplicated cystitis, impetigo, and streptococcal pharyngitis.

This antibiotic plays a role in managing symptom clusters that may become intense or disruptive, including localized pain, redness, swelling, and difficulty with urination. It also serves as a crucial therapeutic alternative for certain patients with non-severe penicillin allergies.

“The use of Cefadroxil in these situations may help ease distress and contribute to improved day-to-day comfort during symptomatic periods.”

The core benefit of this medication is that it contributes to easing the overall symptom load and assists with maintaining functional stability in situations where symptoms are linked to organ-specific functional stress.


Quick Fact: Therapeutic Summary: Focus on Inflammatory and Irritative States

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Ancefa? (Cefadroxil)

The population eligibility for using Ancefa (Cefadroxil) is strictly defined by regulatory documents, focusing on hypersensitivity, organ function, and specific life stages.

Eligibility Status Defined Population Condition/Restriction
Contraindicated Patients with a known allergy to the cephalosporin group of antibiotics Absolute non-eligibility
Restricted Use Patients with a history of severe reactions to penicillins or other beta-lactam drugs Use requires extreme caution due to documented cross-sensitivity risks
Conditional Use Individuals with markedly impaired renal function (creatinine clearance < 50 mL/min/1.73 m^2 or less) Requires caution and monitoring; dosage adjustment is mandated
Age-Group Eligibility Adults and Children (beyond the neonatal period) Use is established; older adults require caution due to potential age-related kidney decline
Reproductive Status Pregnancy (Category B) and Lactation (Nursing Mothers) Should be used during pregnancy only if clearly needed; caution is advised for nursing mothers

Eligibility is further restricted for individuals with a history of gastrointestinal disease, particularly colitis, where the drug must be prescribed with caution. Use in the absence of a proven or strongly suspected bacterial infection is officially discouraged by regulatory bodies.

What should I know about interactions with other medicines?

Ancefa Interactions with Other Medicines and Products

Interactions involving Ancefa (Cefadroxil) are officially documented by regulatory authorities, focusing on changes in drug exposure, pharmacodynamic effects, and diagnostic test interference.

Documented Pharmacokinetic Interactions

Co-administration with the gout medication Probenecid is known to significantly alter the clearance of Cefadroxil. Probenecid inhibits the renal tubular secretion of Cefadroxil, which results in increased plasma concentrations of the antibiotic. This interaction is particularly relevant for individuals with impaired renal function, where Cefadroxil elimination is already reduced.


Documented Pharmacodynamic Interactions

Official labeling identifies two key areas of concern regarding combined use with other medications:

  • Antagonistic Effects: Combining Cefadroxil with bacteriostatic antibiotics, such as tetracycline or chloramphenicol, is discouraged due to the documented possibility of an antagonistic effect on Cefadroxil's action.
  • Potentiated Toxicity: Co-administration with known nephrotoxic agents, including aminoglycoside antibiotics, polymyxin B, and high-dose loop diuretics (like Furosemide), should be avoided as the combination can potentiate nephrotoxic effects.

Interactions with Products and Laboratory Tests

Cefadroxil is documented to interfere with certain diagnostic procedures, potentially leading to inaccurate results:

  • Urine Glucose Tests: A false positive reaction for glucose may occur when using non-enzyme-based copper sulfate solutions (e.g., Clinitest tablets).
  • Coombs' Test: Treatment with Cefadroxil can result in a Positive direct Coombs' test.

Mechanism of Action

Mechanism of Action

Ancefa functions by targeting the final stages of bacterial cell wall biosynthesis. Its primary action is the irreversible inhibition of specific Penicillin-Binding Proteins (PBPs), which act as transpeptidases essential for cross-linking the peptidoglycan structure. This targeted molecular inhibition blocks the crucial structural stabilization of the bacterial cell wall.

This disruption initiates a lethal cascade: the compromised cell wall structure is unable to withstand the organism's high internal osmotic pressure, which, combined with the activation of bacterial autolytic enzymes, causes the cell membrane to rupture (lysis). This sequence of events results in the rapid bactericidal effect against susceptible bacterial cells.

The mechanism is defined by its selectivity, acting exclusively on the peptidoglycan structure absent in host cells. However, its mechanistic integrity is constrained by the presence of bacterial boldsymbolbeta-lactamase enzymes, which chemically inactivate the drug and constrain its capacity to disrupt the cell wall of resistant strains.

Dosage and Administration Information

How Ancefa is Used: Official Administration Guidelines

Ancefa (Cefadroxil) is a prescription antibiotic administered exclusively via the oral route. The official instructions for its use are defined by regulatory agencies, detailing the specific forms, dosing frequency, and administration conditions.


Administration and Dosage Forms

Feature Official Labeled Instructions
Route of Administration Oral use only.
Available Forms Capsules (500 mg), Tablets (1 g), and Powder for Oral Suspension (125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL).
Intake with Food May be taken without regard to meals; however, taking it with food may help minimize potential gastrointestinal discomfort.

Standard Dosing and Duration

Standard adult dosing is typically 1 gram per day, though 2 grams per day may be used for certain complex urinary tract infections. The frequency of administration is either once a day (q.d.) or in two equally divided doses (b.i.d.) depending on the specific infection being treated.

The official duration of use requires that treatment for infections caused by Group A beta-hemolytic Streptococci (e.g., pharyngitis) be maintained for a minimum of 10 days. Patients are instructed to complete the full prescribed course of therapy.

Population-Specific Use Rules

Pediatric Dosing: For children, the dose is generally calculated based on body weight, typically 30 mg/kg/day in single or divided doses.

Renal Impairment: Dosing must be adjusted (reduced and/or interval prolonged) for patients with compromised kidney function (creatinine clearance leq 50 mL/min), as specified in the official label.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ancefa (Cefadroxil)


Evidence for Use in Uncomplicated Urinary Tract Infections (UTI)

Research exploring the effects of Cefadroxil for uncomplicated infections of the urinary tract (UTI) primarily relies on randomized controlled trials (RCTs) and controlled comparison studies. The research examined outcomes related to systemic or functional imbalance, specifically measuring whether the infecting bacteria were eliminated (microbiological cure) and how patient-reported outcomes changed during the study period. Studies monitored both short-term clearance of the pathogen and the change in patient discomfort after a typical course. Studies monitored microbiological cure rates, and findings describe patterns observed in these studies. Contemporary comparative evidence is often lacking, meaning data on how Cefadroxil compares to the newest agents in the context of current antibiotic resistance patterns are not widely established.


Evidence for Use in Skin and Skin Structure Infections (SSSI)

Research exploring Cefadroxil's use in SSSI has utilized randomized, controlled trials and controlled clinical success studies. The included populations cover adults and children with localized, uncomplicated infections such as impetigo and cellulitis. Research examined outcomes related to physical discomfort, focusing on how lesions and symptoms changed and whether the harmful bacteria were eradicated. Studies report patterns observed in the groups studied regarding clinical success, which was measured by criteria defining "cure" or "improvement" of the skin condition. The reported outcomes were primarily short-term and based on defined time intervals. The existing studies provide limited insight into the course of severe or deep-seated SSSI, as the focus was predominantly on uncomplicated infections.


Durability of Response and Research Gaps

Research for Cefadroxil predominantly focuses on short-term symptom changes and episodic outcomes, aligning with the acute nature of the infections studied. The follow-up durations were limited in most key trials, often extending only 2 to 4 weeks after the last dose of the medication. The research does not widely include patients with significant comorbid conditions or infections deemed complicated in controlled trials. Furthermore, official research summaries often note that there are few data available specifically addressing its inclusion in older adults as a defined subgroup, or in pregnant populations.

Frequently Asked Questions (FAQ)

Common questions about Ancefa (FAQ)

Q: Does Ancefa interact with common over-the-counter pain relievers?

A: Official labeling requires caution when taking Ancefa with certain medications that can affect the kidneys (nephrotoxic agents). However, common non-prescription pain relievers, such as acetaminophen or ibuprofen, are not listed as a specific, known interaction in the drug's official product information that requires an explicit warning or adjustment.

Q: What's the difference between Ancefa and other cephalosporin antibiotics?

A: Ancefa (Cefadroxil) is classified as a first-generation cephalosporin antibiotic. This classification generally means it has high activity against specific Gram-positive bacteria, such as Staphylococcus and Streptococcus. Later generations of cephalosporins are typically developed to target a different, often broader, range of bacteria.

Q: How long does Ancefa stay in your system?

A: In adults with normal kidney function, Ancefa (Cefadroxil) has a relatively short half-life, meaning the body eliminates the drug quickly. Official pharmacokinetic data indicate that over 90% of the unchanged drug is typically excreted in the urine within 24 hours of administration.

Q: Are there any specific foods or drinks to avoid while using Ancefa?

A: Official drug information states that Ancefa may be taken with or without food. Taking it with food may help minimize any potential stomach discomfort. No specific foods or drinks are formally listed in regulatory documents as needing to be avoided while using this medication.

Q: Does Ancefa affect birth control pills?

A: Official drug interaction summaries for Ancefa (Cefadroxil) generally do not list a major, established interaction with oral contraceptives (birth control pills). The official label focuses on interactions with other drug classes, such as Probenecid and nephrotoxic agents.

Q: How quickly does Ancefa typically start working?

A: Ancefa is a bactericidal agent, meaning its chemical mechanism of action starts immediately upon administration to kill susceptible bacteria. Patients often observe an improvement in their infection symptoms within the first few days of starting the prescribed treatment course.

Q: What kind of infections does Ancefa target?

A: Ancefa (Cefadroxil) is indicated for treating bacterial infections in specific areas of the body. These indications include infections of the skin and skin structure, the urinary tract, and the upper respiratory tract (such as tonsillitis or pharyngitis caused by susceptible bacteria).

Q: Is Ancefa ever used for skin infections?

A: Yes, Ancefa (Cefadroxil) is indicated for the treatment of skin and skin structure infections (SSSI). Regulatory research overviews confirm that studies have supported its use for specific, uncomplicated infections like impetigo and cellulitis.

Q: What happens if I miss a dose of Ancefa (in a hospital setting)?

A: Official guidance regarding a missed dose indicates that if it is remembered soon after, it should be taken. If it is almost time for the next scheduled dose, the missed dose should be skipped entirely. It is crucial to continue with the regular schedule and avoid taking a double dose.

Q: Can Ancefa cause an allergic reaction, and what are the signs?

A: Yes, Cefadroxil can cause allergic reactions. Signs of less severe reactions documented in the official safety information can include skin changes like a rash, itching (pruritus), or hives (urticaria). More severe, although rare, allergic reactions are also possible.

Q: Is Ancefa safe to use during pregnancy (general information)?

A: Ancefa is classified as Pregnancy Category B. This means that animal studies have not demonstrated a risk to the fetus. However, it is used during pregnancy only after a healthcare provider determines that the potential benefit is judged to outweigh the potential risk.

Q: Can seniors or older adults use Ancefa?

A: Use in older adults is generally established. However, because seniors are more likely to have natural age-related decreases in kidney function, regulatory guidance states that caution and dose adjustments may be required in those with impaired renal clearance.

Q: What research is available on the long-term effects of Ancefa?

A: The research supporting Ancefa's main uses primarily focuses on short-term outcomes that align with acute infection treatment. The key clinical trials generally had limited follow-up durations (often only a few weeks), meaning extensive data on the chronic or long-term effects of the medication are not widely available.

Q: Why do some people experience diarrhea when using Ancefa?

A: Diarrhea is listed as a common side effect in the product's safety information. Antibiotics, including Ancefa, can sometimes disrupt the normal balance of microorganisms in the gut. In rare cases, this imbalance can lead to a serious condition known as Clostridium difficile-associated diarrhea (CDAD).

Q: Does Ancefa interact with common cold or flu medications?

A: Ancefa is designed to treat only bacterial infections and is not effective against viral illnesses like the common cold or flu. While general cold medications are not universally listed as an interaction, the official labeling warns against use with other drugs known to have nephrotoxic (kidney-damaging) properties.

Q: Are there studies supporting the use of Ancefa in specific patient groups?

A: Research overviews indicate that controlled trials for Ancefa often focused on patients with uncomplicated infections and may have excluded individuals with significant co-morbid conditions. Consequently, data on its use in specific, complex patient subgroups may be limited.

Q: What types of bacteria is Ancefa effective against?

A: Official microbiology sections confirm that Ancefa is effective against certain susceptible Gram-positive organisms (such as Staphylococcus and Streptococcus species) and some common Gram-negative organisms (such as Escherichia coli), which are often the cause of the indicated infections.

Q: Can Ancefa cause changes in blood sugar levels?

A: Ancefa can cause a false positive result for glucose (sugar) when specific non-enzyme-based urine tests are used. For individuals monitoring their sugar intake, it is also noted in regulatory information that the oral liquid suspension formulation contains sucrose.

Q: How do you know if Ancefa is working to clear an infection?

A: Ancefa is intended to kill the bacteria causing the infection. Signs that the medication may be effective often include an improvement in symptoms, such as a reduction in fever, pain, redness, or inflammation, typically observed within the first few days of treatment.

Q: Are there generic versions of Ancefa available?

A: Yes. The active ingredient in Ancefa is Cefadroxil, which is widely available from various manufacturers as a generic drug. This is permitted because the FDA has confirmed the original brand-name product was not withdrawn due to safety or effectiveness reasons.

Q: Does Ancefa interact with medications for high blood pressure?

A: The official label does not list common high blood pressure medications as a specific, known interaction. However, caution is advised if combining Ancefa with high-dose loop diuretics (which are sometimes used to manage blood pressure) due to the documented risk of potentiated nephrotoxicity (kidney damage).

Q: Is Ancefa used in veterinary medicine?

A: Yes, regulatory listings, such as the FDA Green Book, indicate that Cefadroxil (the active ingredient) is also an approved drug product for use in veterinary medicine.

Q: How does Ancefa differ from ampicillin?

A: Ancefa (Cefadroxil) is classified as a cephalosporin antibiotic, whereas ampicillin is classified as a penicillin antibiotic. While both belong to the beta-lactam family, they are from different classes and may have differing spectra of activity and susceptibility to bacterial resistance.

How should Ancefa be stored and disposed of?

The storage and disposal of Ancefa (Cefadroxil) are strictly defined by regulatory requirements based on the medicine's form.

Storage Conditions

Form Temperature Requirement Protection / Container Rule
Capsules/Tablets/Powder Controlled Room Temperature (20°C to 25°C) Keep in a tightly closed container, away from excess heat and moisture.
Reconstituted Suspension Store in a refrigerator (2°C to 8°C). Do not freeze. Discard any unused portion after 14 days.

All forms of this medication must be stored in a safe location, out of the reach of children. Unused or expired Cefadroxil should be disposed of according to official local and national regulations. When a drug take-back program is unavailable, official guidance recommends mixing the medicine with an undesirable substance and discarding it in the trash, avoiding release to the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ancefa found in:

A-Z Index: